Myocarditis following COVID-19 mRNA (mRNA-1273) vaccination

Sadeleştirilmiş öğe sayfası
dc.contributor.authorChellapandian, Suresh Babu
dc.contributor.authorTurkmen, Suha
dc.contributor.authorSalim, Imtiaz
dc.contributor.authorChinnakaruppan, Shanmugavel
dc.contributor.authorMohammad, Jassim
dc.date.accessioned2023-02-21T12:32:44Z
dc.date.available2023-02-21T12:32:44Z
dc.date.issued2022-01-01
dc.description.abstractIn this case report, we presented a case of myocarditis as a rare complication that developed after Covid mRNA-1273 vaccine. Cases of post-vaccine myocarditis usually progress with mild symptoms. However, it should be a situation that healthcare workers should keep in mind, that myocarditis may develop after vaccination.
dc.description.issue4
dc.description.issueAPR
dc.description.volume10
dc.identifier.doi10.1002/ccr3.5741
dc.identifier.urihttps://hdl.handle.net/11443/1238
dc.identifier.urihttp://dx.doi.org/10.1002/ccr3.5741
dc.identifier.wosWOS:000783224300001
dc.publisherWILEY
dc.relation.ispartofCLINICAL CASE REPORTS
dc.subjectCovid-19
dc.subjectmRNA-1273 vaccine
dc.subjectmyocarditis
dc.titleMyocarditis following COVID-19 mRNA (mRNA-1273) vaccination
dc.typeArticle

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Thumbnail Image
Ad:
Clinical Case Reports - 2022 - Chellapandian - Myocarditis following COVID‐19 mRNA mRNA‐1273 vaccination.pdf
Boyut:
348.52 KB
Format:
Adobe Portable Document Format
İndir

Koleksiyonlar

WOS